Role of ATP-sensitive K+ channels in the antinociception induced by non-steroidal anti-inflammatory drugs in streptozotocin-diabetic and non-diabetic rats

Pharmacology Biochemistry and Behavior

Volumn 102, Issue 1, 2012, Pages 163-169

  Ortiz, Mario I ^a,b   Castañeda Hernández, Gilberto ^c   Izquierdo Vega, Jeannett A ^a   Sánchez Gutiérrez, Manuel ^a   Ponce Monter, Héctor A ^a   Granados Soto, Vinicio ^c  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^b Servicio de Investigación Del Hospital Del Niño DIF   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Diclofenac; Formalin test; Glibenclamide; Glipizide; Indomethacin; K+ channels; Lumiracoxib; Meloxicam; Metamizol; Streptozotocin diabetic rat

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DICLOFENAC; DIPYRONE; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; INDOMETACIN; LUMIRACOXIB; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; MALE; MOTOR COORDINATION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIABETES MELLITUS, EXPERIMENTAL; KATP CHANNELS; MALE; PAIN MEASUREMENT; RATS; RATS, WISTAR;

RATTUS;

EID: 84861194615     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.03.032     Document Type: Article

References (56)

1. I.I. Acosta-Madrid, G. Castañeda-Hernández, V.G. Cilia-López, R. Cariño-Cortés, N. Pérez- Hernández, and E. Fernández-Martínez Interaction between Heliopsis longipes extract and diclofenac on the thermal hyperalgesia test Phytomedicine 16 2009 336 341
2. P. Aguirre-Bañuelos, and V. Granados-Soto Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test Eur J Pharmacol 395 2000 9 13 (Pubitemid 30227335)
3. + channels activation Life Sci 74 2004 2577 2591 (Pubitemid 38317121)
4. C.I. Araiza-Saldaña, G. Reyes-García, D.Y. Bermúdez-Ocaña, F. Pérez-Severiano, and V. Granados-Soto Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats Eur J Pharmacol 527 2005 60 70 (Pubitemid 41745152)
5. R. Arreola-Espino, H. Urquiza-Marín, M. Ambriz-Tututi, C.I. Araiza-Saldaña, N.L. Caram-Salas, and H.I. Rocha-González Melatonin reduces formalin induced nociception and tactile allodynia in diabetic rats Eur J Pharmacol 577 2007 203 210 (Pubitemid 47632537)
6. B. Bannwarth, and F. Bérenbaum Lumiracoxib in the management of osteoarthritis and acute pain Expert Opin Pharmacother 8 2007 1551 1564 (Pubitemid 47082703)
7. A. Beirith, A.R. Santos, A.L. Rodrigues, T.B. Creczynski-Pasa, and J.B. Calixto Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action Eur J Pharmacol 345 1998 233 245 (Pubitemid 28179563)
8. D.Y. Bermúdez-Ocaña, H. Aguilar-Mariscal, T.R. Frías, J.L. Blé-Castillo, F.J. Flores-Murrieta, and J.C. Díaz-Zagoya Proglumide enhances the antinociceptive effect of cyclooxygenase inhibitors in diabetic rats in the formalin test Eur J Pharmacol 664 2011 8 13
9. R. Björkman Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat Acta Anaesthesiol Scand Suppl 103 1995 1 44
10. N.A. Calcutt, M.C. Jorge, T.L. Yaksh, and S.R. Chaplan Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine Pain 68 1996 293 299 (Pubitemid 27025887)
11. R.K. Campbell Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies J Am Pharm Assoc 49 Suppl. 1 2009 S3 S9
12. A. Chatzigeorgiou, A. Halapas, K. Kalafatakis, and E. Kamper The use of animal models in the study of diabetes mellitus In Vivo 23 2009 245 258
13. F. Diaz-Gonzalez, I. Gonzalez-Alvaro, M.R. Campanero, F. Mollinedo, M.A. del Pozo, and C. Munoz Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs J Clin Invest 95 1995 1756 1765
14. P.J. Dyck, J.L. Davies, D.M. Wilson, F.J. Service, L.J. Melton III, and P.C. O'Brien Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort Diabetes Care 22 1999 1479 1486 (Pubitemid 29418242)
15. P.J. Dyck, J.L. Davies, V.M. Clark, W.J. Litchy, P.J. Dyck, and C.J. Klein Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes Diabetes Care 29 2006 2282 2288 (Pubitemid 44899866)
16. H. Ergün, I.H. Ayhan, and F.C. Tulunay Pharmacological characterization of metamizol-induced relaxation in phenylephrine-precontracted rabbit thoracic aorta smooth muscle Gen Pharmacol 33 1999 237 241 (Pubitemid 29376461)
17. R. Esser, C. Berry, Z. Du, J. Dawson, A. Fox, and R.A. Fujimoto Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2 Br J Pharmacol 144 2005 538 550 (Pubitemid 40349461)
18. R. Fleischmann, I. Iqbal, and G. Slobodin Meloxicam Expert Opin Pharmacother 3 2002 1501 1512 (Pubitemid 35174882)
19. D. Fuchs, F. Birklein, P.W. Reeh, and S.K. Sauer Sensitized peripheral nociception in experimental diabetes of the rat Pain 151 2010 496 505
20. B.J. Gates, T.T. Nguyen, S.M. Setter, and N.M. Davies Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety Expert Opin Pharmacother 6 2005 2117 2140 (Pubitemid 41600587)
21. V. Guastella, and G. Mick Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy Diab Metab 35 2009 12 19
22. A. Junod, A.E. Lambert, L. Orci, R. Pictet, A.E. Gonet, and A.E. Renold Studies of the diabetogenic action of streptozotocin Proc Soc Exp Biol Med 126 1967 201 205
23. A. Junod, A.E. Lambert, W. Stauffacher, and A.E. Renold Diabetogenic action of streptozotocin: relationship of dose to metabolic response J Clin Invest 48 1969 2129 2139
24. D. Kellstein, D. Ott, S. Jayawardene, and J. Fricke Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain Int J Clin Pract 58 2004 244 250 (Pubitemid 38559520)
25. M.R. León-Reyes, G. Castañeda-Hernández, and M.I. Ortiz Pharmacokinetic of diclofenac in the presence and absence of glibenclamide in the rat J Pharm Pharm Sci 12 2009 280 287
26. D.R. Lionberger, and M.J. Brennan Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch J Pain Res 3 2010 223 233
27. J. Lozano-Cuenca, G. Castañeda-Hernández, and V. Granados-Soto Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib Eur J Pharmacol 513 2005 81 91 (Pubitemid 40692249)
28. P. Masiello, C. Broca, R. Gross, M. Roye, M. Manteghetti, and D. Hillaire-Buys Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide Diabetes 47 1998 224 229 (Pubitemid 28079978)
29. E. Mysler Lumiracoxib (Prexige®): a new selective COX-2 inhibitor Int J Clin Pract 58 2004 606 611 (Pubitemid 38996991)
30. A. NoorShahida, T.W. Wong, and C.Y. Choo Hypoglycemic effect of quassinoids from Brucea javanica (L.) Merr (Simaroubaceae) seeds J Ethnopharmacol 124 2009 586 591
31. M. Ocaña, E. Del Pozo, M. Barrios, L.I. Robles, and J.M. Baeyens An ATP-dependent potassium channel blocker antagonizes morphine analgesia Eur J Pharmacol 186 1990 377 378 (Pubitemid 20308273)
32. M. Ocaña, C.M. Cendán, E.J. Cobos, J.M. Entrena, and J.M. Baeyens Potassium channels and pain: present realities and future opportunities Eur J Pharmacol 500 2004 203 219 (Pubitemid 39304009)
33. K. Ogino, K. Hatanaka, M. Kawamura, M. Katori, and Y. Harada Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1 Pharmacology 55 1997 44 53 (Pubitemid 27354666)
34. K. Ogino, K. Saito, T. Osugi, and H. Satoh Meloxicam (Mobic): a review of its pharmacological and clinical profile Nippon Yakurigaku Zasshi 120 2002 391 397 (Pubitemid 36019093)
35. M.I. Ortiz Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides Pharmacol Biochem Behav 99 2011 1 6
36. M.I. Ortiz, and G. Castañeda-Hernández Glibenclamide reduces the diclofenac-induced antihyperalgesia on the Hargreaves model of thermal hyperalgesia Proc West Pharmacol Soc 49 2006 134 136 (Pubitemid 46657585)
37. M.I. Ortiz, J.E. Torres-López, G. Castañeda- Hernández, R. Rosas, G.C. Vidal-Cantú, and V. Granados-Soto Pharmacological evidence for the activation of K(+) channels by diclofenac Eur J Pharmacol 438 2002 85 91 (Pubitemid 34242923)
38. M.I. Ortiz, V. Granados-Soto, and G. Castañeda-Hernández The NO-cGMP-K(+) channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin Pharmacol Biochem Behav 76 2003 187 195 (Pubitemid 38366182)
39. + channels Pharmacol Biochem Behav 74 2003 465 470 (Pubitemid 35449532)
40. + channels by meloxicam in the formalin test Pharmacol Biochem Behav 81 2005 725 731 (Pubitemid 41187804)
41. M.I. Ortiz, J. Lozano-Cuenca, V. Granados-Soto, and G. Castañeda-Hernández Additive interaction between peripheral and central mechanisms involved in the antinociceptive effect of diclofenac in the formalin test in rats Pharmacol Biochem Behav 91 2008 32 37
42. K.M. Ramos, Y. Jiang, C.I. Svensson, and N.A. Calcutt Pathogenesis of spinally mediated hyperalgesia in diabetes Diabetes 56 2007 1569 1576 (Pubitemid 46842613)
43. G. Reid, P. Wielinga, N. Zelcer, I. van der Heijden, A. Kuil, and M. de Haas The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs Proc Natl Acad Sci U S A 100 2003 9244 9249 (Pubitemid 37033914)
44. E. Selg, C. Buccellati, M. Andersson, G.E. Rovati, M. Ezinga, and A. Sala Antagonism of thromboxane receptors by diclofenac and lumiracoxib Br J Pharmacol 152 2007 1185 1195 (Pubitemid 350242444)
45. K. Srinivasan, and P. Ramarao Animal models in type 2 diabetes research: an overview Indian J Med Res 125 2007 451 472 (Pubitemid 46805458)
46. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol Res 50 2001 537 546 (Pubitemid 34087272)
47. G.H. Tesch, and T.J. Allen Rodent models of streptozotocin-induced diabetic nephropathy Nephrology (Carlton) 12 2007 261 266 (Pubitemid 46718209)
48. S. Tesfaye, N. Chaturvedi, S.E. Eaton, J.D. Ward, C. Manes, and C. Ionescu-Tirgoviste Vascular risk factors and diabetic neuropathy N Engl J Med 352 2005 341 350
49. J.R. Vane, and R.M. Botting Mechanism of action of anti-inflammatory drugs Scand J Rheumatol 102 1996 9 21 (Pubitemid 26134842)
50. H. Vanegas Bases for a spinal analgesic action of cyclooxygenase inhibitors Proc West Pharmacol Soc 45 2002 225 227 (Pubitemid 35253097)
51. D.A. Vásquez-Bahena, U.E. Salazar-Morales, M.I. Ortiz, G. Castañeda-Hernández, and I.F. Trocóniz Pharmacokinetic- pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats Br J Pharmacol 159 2010 176 187
52. M. Vlaskovska, S. Surcheva, and R. Ovcharov Importance of endogenous opioids and prostaglandins in the action of analgin (metamizole) and verapamil Farmakol Toksikol 52 1989 25 29 (Pubitemid 19129219)
53. N. Voilley, J. De Weille, J. Mamet, and M. Lazdunski Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors J Neurosci 21 2001 8026 8033 (Pubitemid 32952759)
54. G.Y. Xu, G. Li, N. Liu, and L.Y. Huang Mechanisms underlying purinergic P2X3 receptor-mediated mechanical allodynia induced in diabetic rats Mol Pain 7 2011 60
55. H. Yamamoto, Y. Shimoshige, T. Yamaji, N. Murai, T. Aoki, and N. Matsuoka Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats Neuropharmacology 57 2009 403 408
56. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110 (Pubitemid 13058546)